Pharma IQ has just published the results of its Pharmaceutical Anti-Counterfeiting Survey, conducted in October 2011 among 1,000 pharma anti-counterfeiting specialists. 61.5% respondents found that the threat of counterfeit medicines in the next year was more severe than ever and 53.8% admitted that they were planning to increase their budget for investment in the anti-counterfeiting area. With regard to the anti-counterfeiting technology they were using, only 53% were satisfied with it; over 23% admitted that they weren't content with their current solutions... 
More...
More...